OBJECTIVE To determine age-specific serum anti-Müllerian hormone (AMH) values for women presenting to U.S. fertility clinics. DESIGN Retrospective study. SETTING Single clinical reference laboratory. PATIENT(S) A total of 17,120 women of reproductive age ranging from 24 to 50 years old. INTERVENTION(S) None. MAIN OUTCOME MEASURE(S) Determination of single-year median and mean AMH valu...

Tamoxifen is the drug of choice in the treatment of breast cancer.   Recent reports show an increased incidence of endometrial carcinoma in patients taking tamoxifen.   In this article, we report a case of malignant mixed mullerian tumor after tamoxifen use.

background: careful evaluation of patients and proper treatment with right techniques are essential for successful outcome of assisted reproduction. to obtain satisfactory results, it is necessary to assess ovarian reserve before planning treatment. objective: to evaluate anti-mullerian hormone as a predictor of fertility potential in terms of ovarian reserve and ovarian response reflected by a...

conclusions optimal cytoreductive surgery and chemotherapy may be the best treatment in mmmt but more discussion and experiences are needed regarding the effectiveness of radiotherapy. introduction malignant mixed mullerian tumor (mmmt) is a very rare tumor, accounting for less than 1% of all ovarian cancers. case presentation we present a 64-year-old woman with stage iii mmmt of ovary that was...